Gain Therapeutics (GANX) PT Lowered to $9 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Price: $1.85 +2.21%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Gain Therapeutics (NASDAQ: GANX) to $9.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Upgrades Genius Electronic Optical Co Ltd (3406:TT) to Buy
- Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
- Lucky Strike Entertainment (LUCK) PT Lowered to $10 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
